Immunology

Chronic fatigue syndrome: new evidence of biological causes

Chronic fatigue syndrome (CFS) affects up to 24m people, globally, but little is known about its causes. Our latest study unravels some of this mystery. The results suggest that an overactive immune system may trigger this ...

Diseases, Conditions, Syndromes

Reducing unnecessary medication for hepatitis B patients

Not all chronic hepatitis B (HBV) patients require lifelong treatment; but the risks of blindly withdrawing treatment can be severe. However, there's little consensus on which patients can be safely discontinued from treatment, ...

Diseases, Conditions, Syndromes

At-risk teens and young adults overlooked during opioid crisis

Teens and young adults who have injected drugs are at risk for contracting hepatitis C, but most aren't tested and therefore don't receive life-saving treatment, according to a national study being presented at IDWeek 2018. ...

Diseases, Conditions, Syndromes

Prurigo nodularis more likely in African-Americans

(HealthDay)—African-American patients are more likely to have prurigo nodularis (PN), which is associated with systemic, cardiovascular, and psychiatric comorbidities, according to a study recently published in the Journal ...

Diseases, Conditions, Syndromes

WHO targets for chronic hepatitis B will be cost-effective

(HealthDay)—Meeting World Health Organization (WHO) targets for chronic hepatitis B by 2030 will be cost-effective, according to a report published in the July issue of Health Affairs.

Diseases, Conditions, Syndromes

Canada updates guidelines for hepatitis C virus infection

(HealthDay)—A guideline published in the June 4 issue of CMAJ, the journal of the Canadian Medical Association, provides updated evidence-based recommendations for the treatment of patients with chronic hepatitis C virus ...

page 8 from 35